We have developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples.
The company holds a broad patent portfolio of three patent families. Lumito’s solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
A research group in the Division of Atomic Physics and Laser Centre at Lund University proved the advantages of a medical application of upconverting nanoparticles (UCNP). Their research launched what would later become Lumito AB.
